Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance

NCT06983639 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4000

Last updated 2026-01-15

No results posted yet for this study

Summary

From observational studies, it is know that the risk of developing colorectal cancer after polyp removal is lower if the patients adheres to surveillance recommendations. However, colonoscopy is burdensome for patients and colonoscopy availability is limited in many parts of the world. In addition, more than half of surveillance colonoscopies are without any findings. The trial investigates whether surveillance using fecal testing for blod is as good as colonoscopy after removal of colorectal polyps.

Conditions

  • Colorectal Neoplasms

Interventions

DIAGNOSTIC_TEST

Fecal occult blood testing

Fecal testing for blood as surveillance efter polyp removal

DIAGNOSTIC_TEST

Colonoscopy

Colonoscopy after polyp removal according to guidelines

Sponsors & Collaborators

  • Sykehuset Ostfold

    collaborator OTHER
  • University Hospital, Akershus

    collaborator OTHER
  • Vestre Viken Hospital Trust

    collaborator OTHER
  • Sykehuset Telemark Hospital Trust

    collaborator UNKNOWN
  • Helse Møre og Romsdal HF

    collaborator OTHER_GOV
  • St. Olavs Hospital

    collaborator OTHER
  • University Hospital of Northern Norway, Tromsø, Norway

    collaborator UNKNOWN
  • Sykehuset i Vestfold HF

    collaborator OTHER
  • Helse Stavanger HF

    collaborator OTHER_GOV
  • Turku University Hospital

    collaborator OTHER_GOV
  • Helsinki University Central Hospital

    collaborator OTHER
  • Randers Regional Hospital

    collaborator OTHER
  • Viborg Regional Hospital

    collaborator OTHER
  • Gødstrup Hospital

    collaborator OTHER
  • Horsens Hospital

    collaborator OTHER
  • Sorlandet Hospital HF

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-09
Primary Completion
2040-12-31
Completion
2050-01-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06983639 on ClinicalTrials.gov